Investor · Cranbury, NJ

Bo Liang

Open Bo in the network graph →

Filings

9

SEC Form D

Connections

44

co-filers

Capital

$47.6M

across filings

Active

Feb 2021

to Jun 2025

Most-connected co-filers (44)

Qi Zhu · Cranbury, NJ9 shared Wei H. Wang · Richmond, VA9 shared Xiaolu T. Sun · Cranbury, NJ6 shared John J. Baldwin · Cranbury, NJ5 shared Joseph J. Bonner · Salt Lake City, UT4 shared Sheri Rempel · VANCOUVER, British Columbia, Canada4 shared Carey Dillen · Vancouver, British Columbia, Canada4 shared Katrina Palanca · Vancouver, British Columbia, Canada4 shared Shafin Tejani · Vancouver, British Columbia, Canada4 shared Matthew Bailey · Vancouver, British Columbia, Canada4 shared Diane J. Olmstead · SALT LAKE CITY, UT4 shared Gary S. Crittenden · SALT LAKE CITY, UT4 shared Michael S. Rainen · Englewood, CO4 shared Bin T. He · Cranbury, NJ4 shared Spencer F. Kirk · SALT LAKE CITY, UT4 shared Peter J. Tucker · Chicago, IL2 shared Mike Fitzgerald · Chicago, IL2 shared Garry J. Cooper, Jr · Chicago, IL2 shared Tyler J. Skelton · Chicago, IL2 shared Thomas J. Fecarotta · Chicago, IL2 shared David Meltzer · Vancouver, British Columbia, Canada2 shared Joseph S. Saffire · SALT LAKE CITY, UT2 shared Jingjie Li · Cranbury, NJ2 shared Boris Dorfman · North Hollywood, CA2 shared

Recent filings (9)

IVIEW Therapeutics, Inc.Jun 2025 · 20 co-filers$15.0M IVIEW Therapeutics, Inc.Feb 2025 · 20 co-filers$15.0M IVIEW Therapeutics, Inc.May 2024 · 19 co-filers$15.0M CIFC Investment Grade CLO Fund Ltd.Mar 2022 · 8 co-filers IVIEW Therapeutics, Inc.Jan 2022 · 19 co-filers$30.0M Rheaply, Inc.Jun 2021 · 19 co-filers$2.7M IVIEW Therapeutics, Inc.Mar 2021 · 11 co-filers$24.0M IVIEW Therapeutics, Inc.Mar 2021 · 11 co-filers$24.0M CIFC Investment Grade CLO Fund Ltd.Feb 2021 · 8 co-filers Rheaply, Inc.Feb 2021 · 17 co-filers$10.8M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Bo in the interactive graph →